Medicare Enrolled
Dr. Edna Scheindling-Tokayer, MD
Endocrinology · Boca Raton, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Scheindling-Tokayer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scheindling-Tokayer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Scheindling-Tokayer
Dr. Edna Scheindling-Tokayer is an endocrinology specialist in Boca Raton, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Scheindling-Tokayer performed 5,954 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Scheindling-Tokayer received a total of $21,018 from 70 pharmaceutical and/or device companies across 1176 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Scheindling-Tokayer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in FL
$21,018 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 83403 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,954
Medicare services
Top 10% in FL for endocrinology
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,290 | $19 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,253 | $100 | $225 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
318 | $27 | $80 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
262 | $86 | $243 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
232 | $3 | $10 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
145 | $113 | $320 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
106 | $143 | $302 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
99 | $132 | $345 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
61 | $73 | $150 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
56 | $57 | $168 |
| New patient office visit, complex (60-74 min) | 45 | $177 | $435 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $71 | $152 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
20 | $103 | $270 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
17 | $103 | $200 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
13 | $45 | $90 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$21,018
Total received (2018-2024)
Avg $3,003/year across 7 years
Top 18% in FL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
1,176
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,454
2023
$2,882
2022
$3,472
2021
$3,059
2020
$2,536
2019
$3,064
2018
$2,552
Payments by company (2024)
Lilly USA, LLC
$724
Novo Nordisk Inc
$352
Dexcom, Inc.
$211
Mannkind Corporation
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
SANOFI-AVENTIS U.S. LLC
$163
Xeris Pharmaceuticals, Inc.
$154
Insulet Corporation
$149
Amgen Inc.
$146
Bayer Healthcare Pharmaceuticals Inc.
$140
BETA BIONICS, INC.
$139
Novartis Pharmaceuticals Corporation
$128
Radius Health, Inc.
$109
Antares Pharma, Inc.
$92
Corcept Therapeutics
$91
Abbott Laboratories
$65
Tandem Diabetes Care, Inc.
$55
RECORDATI_RARE_DISEASES_INC.
$55
Medtronic, Inc.
$43
IBSA Pharma Inc.
$37
Alexion Pharmaceuticals, Inc.
$30
Amneal Pharmaceuticals LLC
$29
Madrigal Pharmaceuticals
$29
Ultragenyx Pharmaceutical Inc.
$25
Amphastar Pharmaceuticals, Inc.
$25
Kyowa Kirin, Inc.
$21
Astellas Pharma US Inc
$20
RGH Enterprises LLC
$17
Currax Pharmaceuticals LLC
$17
ABBVIE INC.
$14
CeQur Corporation
$13
Top 3 companies account for 37.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,804
Lilly USA, LLC
$2,548
SANOFI-AVENTIS U.S. LLC
$2,072
AstraZeneca Pharmaceuticals LP
$1,359
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,143
Xeris Pharmaceuticals, Inc.
$983
Amgen Inc.
$761
Corcept Therapeutics
$705
Insulet Corporation
$618
Merck Sharp & Dohme Corporation
$570
Abbott Laboratories
$523
Mannkind Corporation
$516
Radius Health, Inc.
$509
MannKind Corporation
$406
Dexcom, Inc.
$360
Amneal Pharmaceuticals LLC
$306
Bayer Healthcare Pharmaceuticals Inc.
$282
AbbVie, Inc.
$257
Bayer HealthCare Pharmaceuticals Inc.
$257
Horizon Therapeutics plc
$255
AbbVie Inc.
$231
IBSA Pharma Inc.
$192
Zealand Pharma US, Inc.
$182
Antares Pharma, Inc.
$178
Senseonics, Incorporated
$176
Janssen Pharmaceuticals, Inc
$176
Novartis Pharmaceuticals Corporation
$165
Valeritas, Inc.
$154
ABBVIE INC.
$149
Amarin Pharma Inc.
$148
Tandem Diabetes Care, Inc.
$141
BETA BIONICS, INC.
$139
Medtronic, Inc.
$137
RECORDATI_RARE_DISEASES_INC.
$135
LIFESCAN, INC.
$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Shire North American Group Inc
$77
VIVUS LLC
$76
Becton, Dickinson and Company
$71
Embecta Corp.
$69
Alexion Pharmaceuticals, Inc.
$65
DEXCOM, INC.
$63
VIVUS, Inc.
$62
Currax Pharmaceuticals LLC
$59
Nevro Corp.
$53
Amphastar Pharmaceuticals, Inc.
$49
Kyowa Kirin, Inc.
$47
Ultragenyx Pharmaceutical Inc.
$45
PFIZER INC.
$45
Supernus Pharmaceuticals, Inc.
$42
EUSA Pharma (US) LLC
$40
Ascensia Diabetes Care US Inc.
$37
Gemini Laboratories, LLC
$36
Endo Pharmaceuticals Inc.
$34
Acella Pharmaceuticals, LLC
$33
Madrigal Pharmaceuticals
$29
Medtronic MiniMed, Inc.
$28
CeQur Corporation
$26
Ascendis Pharma Inc
$25
Esperion Therapeutics, Inc.
$23
Azurity Pharmaceuticals, Inc.
$21
Astellas Pharma US Inc
$20
Amryt Pharma Holdings Ltd
$18
Strongbridge US INC.
$18
Alfasigma USA, Inc.
$18
RGH Enterprises LLC
$17
LifeScan, Inc.
$17
Tolmar, Inc.
$13
Intuity Medical Inc
$12
Roche Diabetes Care, Inc.
$12
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CONTRAVE · CRYSVITA · CYCLOSET · Cables · CeQur Simplicity · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LEQVIO · LICART · LOKELMA · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid · NP Thyroid 60 · ONETOUCH VERIO REFLECT · Omnipod · One Touch Reveal Mobile App · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Software · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
74
County median income
$81,115
Nearest hospital to ZIP centroid (approximate)
BOCA RATON REGIONAL HOSPITAL
1.9 mi
1.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Scheindling-Tokayer is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Scheindling-Tokayer experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Scheindling-Tokayer performed 3,290 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Scheindling-Tokayer receive payments from pharmaceutical companies?
Yes. Dr. Scheindling-Tokayer received a total of $21,018 from 70 companies across 1,176 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scheindling-Tokayer's costs compare to other endocrinologists in Boca Raton?
Dr. Scheindling-Tokayer's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scheindling-Tokayer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Boca Raton
Browse endocrinologists in Boca Raton ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology